logo
welcome
Wired

Wired

Crispr-Enhanced Viruses Are Being Deployed Against UTIs

Wired
Summary
Nutrition label

79% Informative

Locus Biosciences of North Carolina is adding the gene-editing tool Crispr to the phages’ armory to boost their killing ability.

The company is testing the approach against urinary tract infections, or UTIs, caused by E. coli bacteria.

Results from a small trial published in August suggest the experimental treatment has promise, but larger studies will need to confirm its benefits.

Phage therapy is intended for patients with recurrent UTIs, not a first -time infection.

In the trial, the phage cocktail was given via a catheter that’s inserted into the bladder through the urethra.

The company intends to work on more user-friendly formulations and dosing.

VR Score

78

Informative language

78

Neutral language

49

Article tone

formal

Language

English

Language complexity

57

Offensive language

possibly offensive

Hate speech

possibly hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

Affiliate links

no affiliate links